Antiarrhythmia pacer using antiarrhythmia pacing and autonomic nerve stimulation therapy
US5203326A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Dec 18, 1991 |
| Grant date | Apr 20, 1993 |
| Priority date | — |
| Expiry date | Dec 18, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/365
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
An antiarrhythmia pacemaker detects the occurrence of an abnormal condition of a patient's heart and, in response, delivers an antiarrhythmia therapy to the patient which includes two components, electrical stimulation of the heart and electrical stimulation of nerves or ganglia in the autonomic nervous system. The antiarrhythmia pacemaker controls electrical stimulation of the heart in terms of timing, frequency, amplitude, duration and other operational parameters, to provide such pacing therapies as antitachycardia pacing, cardioversion and defibrillation. A nerve stimulation electrode, which is driven by a nerve fiber pulse stimulator, stimulates preselected nerve fibers within the patient's autonomic nervous system. An arrhythmia therapy control responds to the detection and confirmation of an abnormal heart condition by controlling and coordinating the heart pulse stimulator and the nerve fiber stimulator to direct performance of a combined heart and nerve stimulation therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.